Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis

Abstract

There is evidence that inflammatory processes in multiple sclerosis (MS) are age-dependent. In this study we evaluated the impact of aging on gadolinium (Gd) enhancement of brain magnetic resonance imaging (MRI) lesions in MS patients. Pre- and post-contrast MRI scans, acquired using a standardized procedure by the same MRI scanner, at least 1 month far from clinical relapse or steroid treatment, were examined in 200 disease-modifying treatment free MS patients. Seventy-three patients (36.5%) showed at least one enhancing lesion. Age at MRI examination ( p = 0.0001), disease duration ( p = 0.002) and EDSS score were significantly ( p = 0.02) lower, whereas relapse rate in the preceding 2 years was higher ( p = 0.003) in patients with enhancing lesions than in patients with unenhancing scans. Multivariate logistic analysis showed that current age was the variable better predicting Gd enhancement ( p = 0.004). The odds ratios were 0.95 (CI: 0.92–0.98) for each year of patient's age and 0.64 (CI: 0.48–0.87) for each age decade. The main changes in enhancement risk occurred after 35 years of age. Multivariate Poisson regression model showed that relapse rate in the preceding 2 years ( p < 0.0001) and current age ( p = 0.0003) were the best predictors of the number of enhancing lesions. This information can be used to increase the statistical power of clinical trials using Gd-enhancing lesions as an outcome measure.